Parallax Center

What Parallax Center does

Parallax Center, Inc. is a private outpatient substance abuse treatment and professional detoxification provider founded in 1984 by Dr. David M. Ockert in New York City. The center operates from a single site at 145 East 32nd Street, 6th Floor, in Midtown Manhattan, and is one of the first free-standing outpatient treatment programs established on the East Coast. It is OASAS-certified (New York State Office of Addiction Services and Supports) and accepts a broad set of commercial insurers and Medicaid (excluding 1199 and Medicare), with self-pay available for uninsured patients.

The service portfolio spans four core programs: an Outpatient Detoxification program built around a proprietary non-opioid withdrawal protocol (clonidine, lorazepam, trazodone, and a stimulant) followed by naltrexone induction; the integrated Outpatient 822 Program combining counseling, approved medications, and trauma-informed care for co-occurring disorders; the recently launched (October 2024) Intensive Outpatient Program (IOP); and an OASAS-certified DUI/DWI Assessment and Treatment Track. Adjacent offerings include Medication-Assisted Treatment with Naltrexone (Vivitrol), Suboxone, and Sublocade, Dr. Fingesten's holistic primary care, and LGBTQ+-specific group therapy. All services are delivered in-person and via telehealth. The clinical team comprises doctors, nurses, psychologists, social workers, mental health counselors, and CASACs, led by CEO Jacques Nir, LCSW (Columbia University) and Medical Director Dr. Alexandra Fingesten (in role since 2002).

The revenue model is insurance-led (commercial and Medicaid fee-for-service reimbursement for clinical services) supplemented by self-pay daily-billed detox for uninsured patients. The go-to-market is sales-led, driven by an admissions phone line, email inquiry, and inbound referrals from hospitals, inpatient facilities, primary care providers, and employee assistance programs. The company is privately held, founder-influenced, and has not raised external capital, expanded beyond NYC, or completed material M&A.

Name

Parallax Center

Legal name

Parallax Center Inc.

Website

https://parallaxcenter.com

Company type

Private

Founded year

1984

Operating status

Operating

Headcount range

11–50 employees

Short description

Parallax Center is a private, OASAS-certified outpatient substance abuse treatment and detoxification provider in Manhattan, operating a proprietary non-opioid withdrawal protocol across detox, IOP, 822, DUI/DWI, and MAT programs for individuals with substance use disorders.

Ownership category

akta.pro rank

Product category

Outpatient Addiction Treatment

NAICS

Outpatient Mental Health and Substance Abuse Centers (621420)

SIC

Services-Specialty Outpatient Facilities, Nec (8093)

akta.pro primary industry

Medication-Assisted Treatment (MAT) & Opioid Treatment Programs (OTPs) (HLAFACAG)

akta.pro secondary industries

Outpatient Substance Use Treatment Programs (IOP/PHP/OP) (HLAFACAF), Substance Use Detoxification Centers (Medical Detox) (HLAFACAD)

Keywords

• Outpatient detoxification
• Substance abuse treatment
• Medication-assisted treatment
• Intensive outpatient program
• Behavioral health services

Headquarters

HQ city

New York

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Others, Marketing or Sales, Technology or R&D

Revenue model

1. Insurance-Based Treatment Services: Revenue generated from treating patients with commercial insurance, HMOs, managed care plans, and Medicaid. Services covered include outpatient detoxification, substance use treatment, and mental health services.
2. Out-of-Pocket/Self-Pay: For patients without insurance coverage, services are billed on a daily basis determined by anticipated detox duration. Refunds issued if detox completes earlier than expected.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels7 records

Core offering

Parallax Center provides medically supervised outpatient detoxification and substance use disorder treatment programs, including opioid, alcohol, and benzodiazepine detox using a proprietary non-opioid withdrawal protocol with naltrexone induction. It delivers integrated outpatient treatment (the 822 program), an Intensive Outpatient Program (IOP), outpatient substance use and mental health services, a DUI/DWI assessment and treatment track, medication-assisted treatment (Naltrexone/Vivitrol, Suboxone, Sublocade), and holistic primary care through Dr. Fingesten, all in person and via telehealth.

Product overview

Parallax Center offers a comprehensive outpatient substance abuse treatment portfolio consisting of multiple integrated programs: the Outpatient 822 Program (core integrated treatment), Outpatient Detoxification Program (medical withdrawal management), Intensive Outpatient Program (IOP), DUI/DWI Assessment and Treatment Track, and Outpatient Substance Use and Mental Health Services. The center utilizes a distinctive Non-Opioid Withdrawal Protocol for detoxification and provides Medication-Assisted Treatment (MAT) options including Naltrexone, Suboxone, and Sublocade. Additional services include Dr. Fingesten's Holistic Primary Care for patients seeking MAT care independently. All programs are accessible via both in-person and Telehealth delivery channels.

Differentiator

Problem solved

Functional benefit

Quantifiable outcome

• 61% successful outpatient opioid detoxification completion rate with naltrexone induction
• +1 more outcomes

Named customers3 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

One partnership is on record.

• Argus CommunityminorStrategic or Co-development PartnerParallax Center collaborates with Argus Community to offer HIV and Hepatitis C testing as well as health education services to patients, enhancing comprehensive healthcare offerings beyond substance use treatment.

Scale indicators2 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• BrightView Health: Outpatient addiction treatment provider offering MAT, IOP, detox coordination, and telehealth in multiple states. Closely comparable service mix and target patient population, though at larger scale.
• CleanSlate Outpatient Addiction Medicine: Specialty outpatient addiction medicine provider focused on MAT (buprenorphine, naltrexone, Sublocade) across multiple states. Direct competitor on the medication-assisted outpatient treatment model that Parallax Center offers.
• Addiction Institute of New York: NYC-based outpatient addiction treatment program offering IOP, MAT, and therapy services. Direct competitor in the same geographic market with overlapping service lines.
• Recovery Centers of America: Multi-site addiction treatment provider offering outpatient and inpatient programs with MAT. Direct competitor in outpatient substance use treatment and detox services, though operating a broader regional footprint.

Broad incumbents

• Caron Treatment Centers: Long-standing addiction treatment provider (founded 1957) offering outpatient services alongside residential care in the Northeast. Comparable outpatient substance use programming, family services, and MAT, but with broader geographic footprint.
• Hazelden Betty Ford Foundation: Largest nonprofit addiction treatment provider in the U.S. with both residential and outpatient programs. Comparable in outpatient substance use disorder services and MAT offerings, though substantially larger and nationally distributed.
• NewYork-Presbyterian Hospital Addiction Services: Major NYC academic health system providing outpatient and inpatient addiction treatment including MAT. Comparable in scope of services within the same NYC market but with vastly larger resources and referral pipeline.
• Montefiore Health System Addiction Services: Large NYC health system offering outpatient addiction medicine and MAT, listed as one of Parallax's accepted insurance networks. Competes for the same patient pool in the Bronx/Manhattan market with hospital system resources.
• Mount Sinai Addiction Institute: Hospital-affiliated addiction medicine program in NYC offering outpatient substance use treatment, MAT, and psychiatry. Comparable NYC outpatient service mix with strong referral pull from a large health system.

Regional players

• Odyssey House: NYC-based nonprofit offering residential and outpatient substance use treatment including MAT. Comparable in NYC market and service mix, with stronger scale and Medicaid contracting.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/parallaxcenter
• LinkedInlinkedin.com/company/parallax-center
• Instagraminstagram.com/parallaxcenterinc
• Xx.com/ParallaxCenter

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Parallax Center